[Meningococcal vaccines: present status and perspectives].

Therapie

Unité des Neisseria, Centre National de Référence des Méningocoques, Departement de Médecine Moléculaire, Institut Pasteur, Paris, France.

Published: September 2005

Neisseria meningitidis can cause asymptomatic carriage, followed by acquired immunity, or septicaemia, meningitis, septic arthritis or pericarditis. Vaccination induces protective bactericidal antibodies to invasive diseases. Meningococcal capsular polysaccharides are immunoprotective antigens from which vaccines are produced against serogroups A, C, Y and W135, including conjugate vaccines against serogroup C. There is no available vaccine against serogroup B, but outermembrane protein-based vaccines against this serogroup are currently being evaluated. Polysaccharide meningococcal vaccines are effective, but their strictly serogroup-specific efficacy raises concerns about the possible selection of escape variants. Therefore, meningococcal polysaccharide vaccines, either plain or conjugated, are indicated against the clonal expansion of strains whose serogroup has been properly identified and corresponds to the vaccine valence.

Download full-text PDF

Source
http://dx.doi.org/10.2515/therapie:2005037DOI Listing

Publication Analysis

Top Keywords

vaccines serogroup
8
vaccines
5
[meningococcal vaccines
4
vaccines status
4
status perspectives]
4
perspectives] neisseria
4
neisseria meningitidis
4
meningitidis asymptomatic
4
asymptomatic carriage
4
carriage acquired
4

Similar Publications

Background: Due to high costs of pneumococcal conjugate vaccines (PCV), transitioning from a two (2 + 1) to a single dose (1 + 1) primary series with a booster should be considered. This study evaluated the immune response at 18 months of age following a 1 + 1 compared to a 2 + 1 schedule of 10-valent (PCV10) and 13-valent (PCV13) vaccines.

Research Design And Methods: A single-center, open-label, randomized trial conducted in Soweto, South Africa, evaluated the immunogenicity of differing dosing schedule for PCV10 and PCV13.

View Article and Find Full Text PDF

Self-assembling ferritin nanoparticle technology is a widely used vaccine development platform for enhancing the efficacy of subunit vaccines by displaying multiple antigens on nanocages. The dengue virus (DENV) envelope domain III (EDIII) protein, the most promising antigen for DENV, has been applied in vaccine development, and it is essential to evaluate the relative immunogenicity of the EDIII protein and EDIII-conjugated ferritin to show the efficiency of the ferritin delivery system compared with EDIII. In this study, we optimized the conditions for the expression of the EDIII protein in , protein purification, and refolding, and these optimization techniques were applied for the purification of EDIII ferritin nanoparticles.

View Article and Find Full Text PDF

Cell culture underpins virus isolation and virus neutralisation tests, which are both gold-standard diagnostic methods for foot-and-mouth disease (FMD). Cell culture is also crucial for the propagation of inactivated foot-and-mouth disease virus (FMDV) vaccines. Both primary cells and cell lines are utilised in FMDV isolation and propagation.

View Article and Find Full Text PDF

Foot-and-mouth disease (FMD) continues to pose a significant threat in Egypt, necessitating thorough analyses of FMD virus (FMDV) outbreaks. This study analyzed 144 suspected FMD cases across 52 animal collections during the years 2017-2018 and 2022. Recurrent FMD outbreaks in vaccinated dairy cattle were investigated.

View Article and Find Full Text PDF

Background: Patients with systemic lupus erythematosus (SLE) are susceptible to infectious diseases owing to various immunosuppressive treatments and disease characteristics. Meningococcal infections progress rapidly with a high incidence of severe complications and mortality; therefore, meningococcal vaccination is needed. However, there is limited evidence regarding the immunity and immunogenicity of patients with SLE.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!